Dr. Olga Kubassova, Dr Alex Iakimov and Prof. Mikael Boesen of IAG will attend at IWOAI.
Dr. Kubassova, Dr. Iakimov and Dr. Boesen will be joining the International Workshop on Osteoarthritis Imaging, 28-30 June 2023. This meeting provides an interactive environment for those interested in osteoarthritis imaging to learn and network. Participants represent the diverse scope of the field and include professionals from specialties including medicine, surgery, radiology, medical physics and physiotherapists, as well as a broad array of professional backgrounds including academia, industry, government and regulatory agencies.
The CEO of IAG, Image Analysis Group, Dr. Olga Kubassova, will be moderating a panel discussion on the topic of “Artificial Intelligence in Osteoarthritis: Research Prospective”.
In the previous workshop, she has already spoken on the subject of access to data, data sharing and its use in drug development. Next week’s session addresses one of the most important challenges for the Drug Development industry and researchers – how to deploy AI in understanding drugs’ mechanism of action and efficacy.
Join the speakers on Thursday, 29th June, 14:30 – 16:00 Session 5: “AI in OA”: research perspective”
Moderator: Olga Kubassova
14:30 – 14:45 Keynote speaker: The hype of AI in OA: where are we in 2023? – Richard Kijowski
14:45 – 15:00 Keynote speaker: Building disease models using AI – Jonas Richiardi
15:00 – 16:00 Four abstracts
Dr John Carrino, member of IAG’s Scientific Advisory Board will give a talk ‘Novel imaging methods: what is in the pipeline?’
Join the speakers on Thursday, 11:00 – 12:30 Session 4: “Imaging: what is new?”
Moderator: Thomas Link
11:00 – 11:15 Keynote speaker: Novel imaging methods: what is in the pipeline? – John Carrino
11:15 – 11:30 Keynote speaker: Imaging of OA: beyond the joints – Shadpour Demehri
11:30 – 12.30 Four abstracts
The International Workshop on Osteoarthritis Imaging started in 2007. Imaging is critical in both the diagnosis and management of osteoarthritis. Clinical and epidemiological studies characteristically utilize imaging-derived inclusion/exclusion criteria as well imaging based outcome measures. This Workshop was established to offer opportunities for osteoarthritis investigators to discuss issues related to imaging of osteoarthritis. The topics of discussion may include new lessons learned about osteoarthritis pathophysiology by using imaging modalities, recent advances in imaging techniques and appropriate analytic methods of imaging derived data.
About Image Analysis Group (IAG)
IAG, Image Analysis Group is a unique partner to life sciences companies. IAG leverages expertise in medical imaging and the power of Dynamika™ – our proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner. IAG provides early drug efficacy assessments, smart patient recruitment and predictive analysis of advanced treatment manifestations, thus lowering investment risk and accelerating study outcomes. IAG bio-partnering takes a broader view on asset development bringing R&D solutions, operational breadth, radiological expertise via risk-sharing financing and partnering models.
Learn more: www.ia-grp.com
Reach out: firstname.lastname@example.org
Follow the Company: Linkedin